Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Feb;68(2):205–209. doi: 10.1136/adc.68.2.205

Metabolic effects of growth hormone treatment: an early predictor of growth response?

J W Gregory 1, S A Greene 1, R T Jung 1, C M Scrimgeour 1, M J Rennie 1
PMCID: PMC1029236  PMID: 8481042

Abstract

Fourteen children receiving one year of recombinant human growth hormone (rhGH) treatment underwent measurement of serial changes in body composition (measured by skinfold thickness, bioelectrical impedance, and H2(18)O dilution), resting energy expenditure (REE, estimated by ventilated hood indirect calorimetry), and total free living daily energy expenditure (TEE, measured by the doubly labelled water technique). Mean height velocity increased from 4.9 to 8.6 cm/year after six months of treatment. Fat free mass (FFM) increased more during the first six weeks (24.4 g/day) than from six to 26 weeks of treatment (6.8 g/day); fat mass decreased by 7.2 g/day and 1.1 g/day respectively. The six week increase in REE (kJ/day) was maintained after six months of treatment, though expressed per kilogram FFM (kJ/kgFFM/day), returned to pretreatment values by three months. Height velocity increases at six months correlated with six week changes in fat mass measured by skinfold thickness and REE, though use of this relationship to predict growth response in individuals is limited by the wide 95% prediction intervals. No significant changes in growth, body composition, or energy expenditure were observed between six and 12 months of treatment, in either patients who had initially responded well to treatment or those who were poor initial responders to treatment and who had their dose of rhGH doubled after six months.

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clayton B. E., Tanner J. M., Vince F. P. Diagnostic and prognostic value of short-term metabolic response to human growth hormone in short stature. Arch Dis Child. 1971 Aug;46(248):405–413. doi: 10.1136/adc.46.248.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dahms W. T., Owens R. P., Kalhan S. C., Kerr D. S., Danish R. K. Urea synthesis, nitrogen balance, and glucose turnover in growth-hormone-deficient children before and after growth hormone administration. Metabolism. 1989 Mar;38(3):197–203. doi: 10.1016/0026-0495(89)90075-9. [DOI] [PubMed] [Google Scholar]
  3. Gertner J. M., Genel M., Gianfredi S. P., Hintz R. L., Rosenfeld R. G., Tamborlane W. V., Wilson D. M. Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr. 1984 Feb;104(2):172–176. doi: 10.1016/s0022-3476(84)80987-7. [DOI] [PubMed] [Google Scholar]
  4. Gregory J. W., Greene S. A., Jung R. T., Scrimgeour C. M., Rennie M. J. Changes in body composition and energy expenditure after six weeks' growth hormone treatment. Arch Dis Child. 1991 May;66(5):598–602. doi: 10.1136/adc.66.5.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gregory J. W., Greene S. A., Scrimgeour C. M., Rennie M. J. Body water measurement in growth disorders: a comparison of bioelectrical impedance and skinfold thickness techniques with isotope dilution. Arch Dis Child. 1991 Feb;66(2):220–222. doi: 10.1136/adc.66.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gregory J. W., Greene S. A., Thompson J., Scrimgeour C. M., Rennie M. J. Effects of oral testosterone undecanoate on growth, body composition, strength and energy expenditure of adolescent boys. Clin Endocrinol (Oxf) 1992 Sep;37(3):207–213. doi: 10.1111/j.1365-2265.1992.tb02312.x. [DOI] [PubMed] [Google Scholar]
  7. Grunt J. A., Howard C. P., Daughaday W. H. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism. Acta Endocrinol (Copenh) 1984 Jun;106(2):168–174. doi: 10.1530/acta.0.1060168. [DOI] [PubMed] [Google Scholar]
  8. HENNEMAN P. H., FORBES A. P., MOLDAWER M., DEMPSEY E. F., CARROLL E. L. Effects of human growth hormone in man. J Clin Invest. 1960 Aug;39:1223–1238. doi: 10.1172/JCI104138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hindmarsh P. C., Brook C. G. Effect of growth hormone on short normal children. Br Med J (Clin Res Ed) 1987 Sep 5;295(6598):573–577. doi: 10.1136/bmj.295.6598.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LIFSON N., GORDON G. B., McCLINTOCK R. Measurement of total carbon dioxide production by means of D2O18. J Appl Physiol. 1955 May;7(6):704–710. doi: 10.1152/jappl.1955.7.6.704. [DOI] [PubMed] [Google Scholar]
  11. Milner R. D., Russell-Fraser T., Brook C. G., Cotes P. M., Farquhar J. W., Parkin J. M., Preece M. A., Snodgrass G. J., Mason A. S., Tanner J. M. Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) 1979 Jul;11(1):15–38. doi: 10.1111/j.1365-2265.1979.tb03043.x. [DOI] [PubMed] [Google Scholar]
  12. Plotnick L. P., Van Meter Q. L., Kowarski A. A. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation. Pediatrics. 1983 Mar;71(3):324–327. [PubMed] [Google Scholar]
  13. Rosenbaum M., Gertner J. M., Leibel R. L. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab. 1989 Dec;69(6):1274–1281. doi: 10.1210/jcem-69-6-1274. [DOI] [PubMed] [Google Scholar]
  14. Schoeller D. A., van Santen E. Measurement of energy expenditure in humans by doubly labeled water method. J Appl Physiol Respir Environ Exerc Physiol. 1982 Oct;53(4):955–959. doi: 10.1152/jappl.1982.53.4.955. [DOI] [PubMed] [Google Scholar]
  15. Tanner J. M., Hughes P. C., Whitehouse R. H. Comparative rapidity of response of height, limb muscle and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency. Acta Endocrinol (Copenh) 1977 Apr;84(4):681–696. doi: 10.1530/acta.0.0840681. [DOI] [PubMed] [Google Scholar]
  16. Trivedi P., Hindmarsh P., Risteli J., Risteli L., Mowat A. P., Brook C. G. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen. J Pediatr. 1989 Feb;114(2):225–230. doi: 10.1016/s0022-3476(89)80787-5. [DOI] [PubMed] [Google Scholar]
  17. Voss L. D., Wilkin T. J., Bailey B. J., Betts P. R. The reliability of height and height velocity in the assessment of growth (the Wessex Growth Study) Arch Dis Child. 1991 Jul;66(7):833–837. doi: 10.1136/adc.66.7.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WRIGHT J. C., BRASEL J. A., ACETO T., Jr, FINKELSTEIN J. W., KENNY F. M., SPAULDING J. S., BLIZZARD R. M. STUDIES WITH HUMAN GROWTH HORMONE (HGH). Am J Med. 1965 Apr;38:499–516. doi: 10.1016/0002-9343(65)90128-2. [DOI] [PubMed] [Google Scholar]
  19. Wales J. K., Milner R. D. Changes in leg length and height during treatment with somatotropin. Arch Dis Child. 1989 Dec;64(12):1708–1712. doi: 10.1136/adc.64.12.1708. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES